Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:251  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 


 
   Table of Contents     
ORIGINAL ARTICLE  
Year : 2022  |  Volume : 14  |  Issue : 2  |  Page : 75-80
Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent and percutaneous nephrostomy tube


1 Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
2 Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

Click here for correspondence address and email

Date of Submission11-Oct-2021
Date of Acceptance13-Apr-2022
Date of Web Publication29-Jun-2022
 

   Abstract 


Introduction: Infections associated with catheter in the upper urinary tract (CUUT), which include the double-J stent and the percutaneous nephrostomy (PCN) tube, get particularly infected in patients with specific risk factors for developing an infection. Methods: A retrospective observational study was carried out by compiling data from the hospital information system of a tertiary care center from 2019 to 2021 to evaluate infections in patients with catheter in the upper urinary tract. Result: A total of 200 pus samples of double-J stent (96 pus samples) and PCN tube (104 pus samples) were included in our study. Among patients with nephrostomy tube, the most frequently isolated microorganisms were Escherichia coli, followed by Pseudomonas spp. In those with a double-J stent, Pseudomonas aeruginosa, followed by E. coli were the most commonly isolated microorganisms. We found 55.72% of cases of Enterobacteriaceae-producing carbapenemases in patients with a percutaneous catheter. 66.07% of Enterobacteriaceae in patients with double-J and nephrostomy stents are extended-spectrum beta-lactamase-producing bacteria. The percentage of cultures with multiple-drug resistance (MDR) microorganisms was 38.54% in patients with double-J stents and 37.75% in nephrostomy tubes. The presence of prior urinary tract infection (P = 0.010), presence of urinary catheter before admission (P = 0.005), increased time with single urinary catheter in-situ (P < 0.001), and increased length of hospital stay (P = 0.036) were risk factors for isolation of MDR microorganisms. Conclusion: Pseudomonas spp. and Pseudomonas aeruginosa are commonly infecting both the CUUT. E. coli infections are more commonly infecting the nephrostomy tubes. MDR microorganisms are frequent, mainly in patients with prior urinary tract infection, presence of urinary catheter before admission, and prolonged use of a single catheter.

Keywords: Bacteria, colonization, double-j stent, nephrostomy tube, urinary tract infection

How to cite this article:
Kar M, Dubey A, Patel SS, Siddiqui T, Ghoshal U, Sahu C. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent and percutaneous nephrostomy tube. J Global Infect Dis 2022;14:75-80

How to cite this URL:
Kar M, Dubey A, Patel SS, Siddiqui T, Ghoshal U, Sahu C. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent and percutaneous nephrostomy tube. J Global Infect Dis [serial online] 2022 [cited 2022 Aug 19];14:75-80. Available from: https://www.jgid.org/text.asp?2022/14/2/75/348890





   Introduction Top


The derivation of the upper urinary tract through a nephrostomy or double-J stent is performed for the management of obstructive uropathy.[1],[2] The placement of self-retaining double-J stents has become accepted in a wide range of applications, such as relief of obstruction, prevention of stricture formation, treatment of urinary tract leaks, and facilitation of fragment clearance after extracorporeal shock wave lithotripsy. The advent of extracorporeal shock wave lithotripsy and a more rapid increase in endourologic techniques have dramatically increased the indications for indwelling ureteral stents.[3],[4],[5],[6],[7] With regard to indications for placement, the percutaneous nephrostomy (PCN) has evolved since its inception from an exclusively inpatient procedure to an outpatient procedure and from a predominantly temporary method for achieving drainage to a permanent fixture, especially as a palliative care option in patients with obstructive malignancy along the course of the renal drainage system.[8],[9],[10] Catheters for the upper urinary tract are simple to place and are secure devices, but they are not free of complications, and urinary infections are among the most prevalent and potentially serious.[11],[12],[13]

It is usually assumed that double-J stent-associated infection is rare and asymptomatic, although it may be associated with significant morbidity, fever, acute pyelonephritis, bacteremia, vesicoureteral reflux, chronic renal failure, and even death.[14],[15],[16] Health-care providers diagnose infectious complications associated with PCN and offer treatment in an era of evidence-based medicine while using clinical acumen. We reviewed the literature to address this question because the Indian Direct Selling Association guidelines for prevention, diagnosis, and treatment of catheter-associated urinary tract infection categorically exclude the percutaneous nephrostomy catheter PCNC and do not address diagnostic or treatment approaches for infections associated with nephrostomy catheters.[17] Infections related to catheters in the upper urinary tract require specific management due to a high resistance rate. Therefore, the isolation of multiple-drug resistance (MDR) microorganisms is more common, including multi-resistant Pseudomonas, extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae or those resistant to carbapenemases, Enterococcus resistant to vancomycin, and Methicillin-Resistant Staphylococcus aureus (MRSA).[18]

Our purpose was to analyze the microorganisms patterns in infections associated with indwelling double-J stents and/or PCN tubes. We also reviewed multidrug resistance in our environment while paying particular attention to MDR microorganisms and its risk factors.


   Methods Top


We performed a retrospective observational study from November 2019 to September 2021 to evaluate infections in patients with catheters in the upper urinary tract in the Bacteriology section at a Tertiary care center in Northern India.

We included all patients with nephrostomy catheter and double-J stent with a clinical diagnosis of stent or catheter-related infection. An infection was defined by a fever or symptoms and signs of urosepsis. We differentiated between patients who seemed to have acquired the urinary tract infection before admission (community-acquired infections) and hospitalized patients with infections that developed the infection nosocomially, by closely monitoring the period of hospitalization.

In all cases, urine culture was performed before administration, changing or removal of double-J stent and/or PCN tubes. In patients with a nephrostomy tube, the sample for microscopy and culture was collected by aspirating with a syringe after disinfecting the site of the tube where the sterile needle is inserted; the needle tip should also be disinfected before aspiration. For the correct interpretation of the microbiological results in the department of microbiology, only specifically labeled samples of the double-J stent and PCN were accepted as samples collected from a catheter in the upper urinary tract (CUUT).

In this study, we have observed the demographic characteristics, including age, gender, and comorbidities, such as diabetes, hypertension, cardiac and liver disease, immunosuppression, and the American Society of Anesthesiologists' physical status score.[19],[20] Immunosuppression was defined as patients receiving treatment with immunosuppressant drugs, hematological malignancies, transplant recipients, and patients suffering from uncontrolled diabetes. We have also observed the cause of catheter placement among lithiasis, tumor, and other causes of urinary tract obstruction.

Microbiological characteristics and drug resistance patterns were analyzed for all the samples included in the study. Bacterial isolates were identified by routine morphological methods. Antibiotic sensitivity was detected by the Kirby–Bauer disc-diffusion method as well as the automated Vitek method (Biomerieux, France). We also demonstrated the risk factors for isolation of MDR microorganisms, among which are Pseudomonas resistant to at least three antibiotic groups, carbapenemases-resistant and ESBL-producing Enterobacteriaceae, Enterococcus resistant to vancomycin, and MRSA.[21],[22]

Matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) was used for species identification of selected isolates of Pseudomonas species and other nonfermenters. The Pseudomonas species isolate for analysis by MALDI-TOF-mass spectrometry (MALDI-TOF-MS) was prepared by mixing or coating with a solution of an energy-absorbent, organic compound called matrix. When the matrix crystallizes has dried, the isolate entrapped within the matrix also co-crystallizes. The isolate within the matrix ionizes in an automated mode with a laser beam. Desorption and ionization with the laser beam generate singly protonated ions from analytes in the isolate. The protonated ions were then accelerated at a fixed potential, where these separate from each other on the basis of their mass-to-charge ratio (m/z). The charged analytes were then detected and measured using different types of mass analyzers such as quadrupole mass analyzers, ion trap analyzers, and time-of-flight (TOF) analyzers. For microbiological applications, mainly TOF mass analyzers were used. During MALDI-TOF analysis, the m/z ratio of an ion is measured by determining the time required for it to travel the length of the flight tube. A few TOF analyzers incorporate an ion mirror at the rear end of the flight tube, which serves to reflect back ions through the flight tube to a detector. Thus, the ion mirror not only increases the length of the flight tube but it also corrects small differences in energy among ions.[23]

The statistical analysis for our study was performed by observing frequencies. Quantitative variables were expressed as mean and standard deviation. In the analysis of risk factors for MDR, the comparison between groups for categorical variables was estimated using Chi-square tests. The results were presented as 95% confidence interval. Statistical analysis was performed using the software program IBM SPSS Statistics version 20.0 (SPSS Inc., Armonk, NY, USA), with P < 0.05 considered statistically significant.


   Results Top


The study includes 200 patients with CUUT and infection. One hundred and four patients in the study had only PCN tube and 96 patients had only double-J stent. Ninety-six patients had double-J stent (13 with community-acquired infection and 40 developed the infection during hospitalization) and 104 had a PCN tube (15 with community-acquired and 43 with hospital-acquired infection). Catheter insertion was related to urolithiasis in 57.29% of cases with a double-J stent and the percentage marginally decreased to 49.03% in those with PCN tube, respectively. The reason for urinary diversion in patients with double-J stent and nephrostomy, was due to a tumor, in 22.91% and 25.96%, respectively. Among those with a double-J stent, 30.20% had an infection in the previous months, and 30.7% of those with PCN tube. [Table 1] shows the descriptive characteristics.
Table 1: Descriptive analysis of demographic characteristics and risk factors in patients with a catheter in the upper urinary tract (n=200)

Click here to view


Out of the total cases enrolled in our study, 93 (46.5%) cases did not develop any infection. In patients with a double-J stent, the microorganism most frequently isolated was Pseudomonas aeruginosa (21.0%), followed by Escherichia coli (17%) and Pseudomonas spp. (16%). According to the origin of the infection, E. coli was isolated in 39.28% of positive cultures with community-acquired infection, in comparison with 16.86% for E. coli and Enterococcus faecalis in hospital-acquired infections. During hospitalization, the patients developed an infection with Pseudomonas spp., and Pseudomonas aeruginosa in 36.14%, in comparison with 7.14% in community-acquired infections. The most commonly isolated Pseudomonas species were Pseudomonas putida and Pseudomonas stutzeri, as identified by MALDI-TOF-MS. Candida spp. was isolated in 2% and 8.77% for double-J stent and PCN tube, respectively [Figure 1]. For those with a nephrostomy tube, the most frequently isolated microorganism was E. coli (24.56%), followed by Pseudomonas spp. (14.03%) and Klebsiella pneumoniae (14.03%). As all the isolates of Pseudomonas species were not subjected to MALDI-TOF-MS, the exact percentage of the commonly acquired species could not be obtained. In patients with community-acquired infection, E. coli (30.76%), Klebsiella spp. (15.38%), and Proteus mirabilis (15.38%) were the most common bacteria. E. coli was isolated in 30.76% and 17.72% in community- and nosocomially acquired infections, respectively [Figure 1]. The percentage of patients with sterile cultures was 7.69% in community-acquired and 5.06% in nosocomially acquired infections. Pseudomonas aeruginosa was isolated in 3.84% and 18.98% of community- and nosocomially acquired infections, respectively. Enterococcus spp. represented 6.33% of microorganisms isolated in hospital-acquired infections [Figure 1].
Figure 1: Microorganisms isolated from patients with double-j stent and nephrostomy tube (N = 107). PCN: Percutaneous nephrostomy

Click here to view


Multidrug-resistant Enterobacteriaceae in this study are 37, of which 35.13% showed resistance to third-generation cephalosporin in those with a double-J stent, 63.15% with a nephrostomy tube. Among Enterobacteriaceae, E. coli showed higher rates of resistance: 13.51% were ESBL-producing E. coli in patients with double-J, 29.72% with a nephrostomy tube. ESBL-producing Klebsiella spp. were found in 10.81% and 21.62% of patients with double-J and nephrostomy, respectively. Carbapenem-resistant organisms isolated from the study are 55 (Carbapenem-resistant organisms isolated from DJ stent are 26 and those isolated from nephrostomy tube are 29), of which Carbapenem-resistant Pseudomonas aeruginosa isolated from DJ stent is 26.92% and 10.34% for the nephrostomy tube. In addition, Pseudomonas aeruginosa showed resistance to piperacillin-tazobactam in 69.23% and 15.38% in patients with double-J and nephrostomy, respectively. A high resistance rate to quinolones was observed, in patients with isolation of E. coli from double-J stents, with 88.89% (8 out of 9). Cultures where Pseudomonas aeruginosa were isolated showed a resistance rate to aminoglycosides up to 70%, while in the case of E. coli and Klebsiella, the resistance rate was around 44%. Finally, vancomycin is effective in the treatment of Enterococcus spp.

The percentage of cultures with MDR microorganisms was 38.54% in patients with double-J stents and 36.53% in nephrostomy tubes. The isolation of MDR organisms from the community and nosocomially acquired infections is statistically significant (P < 0.05). [Table 2] demonstrates that there is also a statistical significance between the existence of prior urinary tract infection within 1 month of CUUT infection, dependence on urinary catheter before admission for DJ stent and/or nephrostomy tube placement, increased time with single urinary catheter in-situ and the number of days spent in the hospital to diagnose the cause of isolation of MDR microorganisms from the double-J stent and nephrostomy tubes.
Table 2: Risk factors for isolation of multiple.drug resistance microorganisms in patients with a catheter in the upper urinary tract (n=75)

Click here to view



   Discussion Top


CUUT is used to manage urinary obstructions and to facilitate urinary drainage after surgery in the upper urinary tract. Therefore, complications related to different types of catheter-associated upper urinary tract are becoming increasingly important.[24],[25] Infectious complications are the most frequent as CUUT may be associated with significant morbidity and even death.[26] Very few articles describe the infectious complications and microbiological profiles related to CUUT. A distinguishing point in comparison of a CUUT and of a urinary catheter in the lower urinary tract is the difference in the resistance pattern and also the difference in microbial flora in both the types of urinary catheterization. As seen from our data, Pseudomonas aeruginosa is the most commonly isolated microorganism in patients with a double-J stent, followed by E. coli and Pseudomonas spp., which mostly consists of Pseudomonas stutzeri and Pseudomonas putida which are isolated more commonly in our laboratory. These data are in concordance with other studies, which showed that Pseudomonas, Enterococcus, and Candida albicans are often found in patients with CUUT.[26],[27],[28],[29],[30] MRSA was found in 2% of positive cultures. The prevalence of S. aureus was below those found in similar series, above 10%.[13] The use of a sterile technique during the collection of samples from an individual with a double-J stent in situ or with a PCN tube has led to decreased isolation of S. aureus from these samples. In an article by Bonkat et al.,[31] patients with a suprapubic catheterization also showed that Enterobacteriaceae and Enterococcus are the most common microorganisms. In our study, S. aureus and Coagulase-Negative Staphylococcus spp. are isolated in 4% and 2% of cultures, respectively. Therefore, there is increased isolation of microorganisms other than E. coli, Pseudomonas being the most common isolate from patients who had undergone double-J stenting and PCN. Finally, C. albicans is isolated in 8.77% in patients with PCN tube and/or in 2% of patients who had undergone double-J stenting. The highest percentage of C. albicans was observed in patients with PCN, 8.77%. Apart from the specific microbiological profile found in patients with CUUT. In concordance with a study by Vargas-Cruz et al.,[32] the highest susceptibility data are observed in patients with PCN, especially when E. coli is isolated, 48% of Enterobacteriaceae in patients with double-J and nephrostomy stents are ESBL-producing bacteria.

MDR microorganism isolation is a significant concern in patients with CUUT. It accounts for 70% of the microorganisms isolated from positive cultures. In our study, we found 62.06% of cases of Enterobacteriaceae-producing carbapenemases in patients with a percutaneous catheter. Thirty-eight (36.53%) pus samples from PCN were multidrug resistant. Out of the 38 samples that had isolated MDR microorganisms, 39.47% Enterobacteriaceae microorganisms isolated had prior urinary tract infections. Therefore, it is essential to review previous cultures when selecting an empirical treatment. The selection of antibiotic management should be based on the microbiological characteristics and antibiotic resistance of the area to improve the adequacy of antibiotic treatment.[33] According to our data, we recommend the need to adhere to the sensitivity pattern of the microorganisms as it can help in preventing the multidrug resistance in the isolates and starting empirical antibiotics after sending a single aspirate from the nephrostomy tube and double-J stent for identifying the microbiological flora and specific antimicrobial sensitivity. The risk factors for the isolation of MDR microorganisms have been evaluated in our study. According to our data, increase in the time with catheter insertion, the presence of urinary catheter before admission, and the presence of urinary tract infection on admission were statistically significant with the risk of isolation of multidrug-resistant microorganisms from the double-J stent and PCN aspirates. However, deranged blood sugar levels did not predispose to cause more infections. In our study, Pseudomonas and E. coli are the more frequently isolated nosocomially acquired microorganisms. Our study has several limitations. First, it was a retrospective study conducted in a single center, so the patient specifics had to be obtained from the hospital information system. Second, the incidence of community- and hospital-acquired infections could not be calculated because we do not have an accurate record of all patients with CUUT.


   Conclusion Top


Infections related to CUUT showed a specific microorganism pattern. The infections related to PCN and double-J stent are mostly caused by microorganisms such as E. coli, Pseudomonas, K. pneumonia, and Enterococcus spp., when samples were collected by maintaining all aseptic precautions. MDR microorganisms are frequently isolated from these samples and their incidence should be curbed by adhering to specific antibiotic sensitivity patterns to prevent further development of resistance. They also require stringent hospital infection control practices to cease the spread of nosocomial spread of infection.

Research quality and ethics statement

The study was approved by the institute ethics committee (IEC-IMP-2021-188). The authors followed applicable EQUATOR Network (http://www.equator-network.org/) guidelines during the conduct of this research project.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Paick SH, Park HK, Oh SJ, Kim HH. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology 2003;62:214-7.  Back to cited text no. 1
    
2.
Mendez-Probst CE, Fernandez A, Denstedt JD. Current status of ureteral stent technologies: Comfort and antimicrobial resistance. Curr Urol Rep 2010;11:67-73.  Back to cited text no. 2
    
3.
Laverson PL, Hankins GD, Quirk JG Jr. Ureteral obstruction during pregnancy. J Urol 1984;131:327-9.  Back to cited text no. 3
    
4.
Lang EK, Lanasa JA, Garrett J, Stripling J, Palomar J. The management of urinary fistulas and strictures with percutaneous ureteral stent catheters. J Urol 1979;122:736-40.  Back to cited text no. 4
    
5.
LeRoy AJ, Williams HJ Jr., Segura JW, Patterson DE, Benson RC Jr. Indwelling ureteral stents: Percutaneous management of complications. Radiology 1986;158:219-22.  Back to cited text no. 5
    
6.
Ansong K, Khashu B, Lee WJ, Smith AD. Prophylactic use of ureteral stent in iatrogenic injuries to ureter. Urology 1985;26:45-9.  Back to cited text no. 6
    
7.
Ball AJ, Gingell JC, Carter SS, Smith PJ. The indwelling ureteric stentThe Bristol experience. Br J Urol 1983;55:622-5.  Back to cited text no. 7
    
8.
Goodwin WE, Casey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. J Am Med Assoc 1955;157:891-4.  Back to cited text no. 8
    
9.
Stables DP, Ginsberg NJ, Johnson ML. Percutaneous nephrostomy: A series and review of the literature. AJR Am J Roentgenol 1978;130:75-82.  Back to cited text no. 9
    
10.
Montvilas P, Solvig J, Johansen TE. Single-centre review of radiologically guided percutaneous nephrostomy using “mixed” technique: Success and complication rates. Eur J Radiol 2011;80:553-8.  Back to cited text no. 10
    
11.
Richter S, Ringel A, Shalev M, Nissenkorn I. The indwelling ureteric stent: A 'friendly' procedure with unfriendly high morbidity. BJU Int 2000;85:408-11.  Back to cited text no. 11
    
12.
Lange D, Bidnur S, Hoag N, Chew BH. Ureteral stent-associated complicationsWhere we are and where we are going. Nat Rev Urol 2015;12:17-25.  Back to cited text no. 12
    
13.
Siddiq DM, Darouiche RO. Infectious complications associated with percutaneous nephrostomy catheters: Do we know enough? Int J Artif Organs 2012;35:898-907.  Back to cited text no. 13
    
14.
Warren JW, Muncie HL Jr., Hall-Craggs M. Acute pyelonephritis associated with bacteriuria during long-term catheterization: A prospective clinicopathological study. J Infect Dis 1988;158:1341-6.  Back to cited text no. 14
    
15.
Warren JW, Muncie HL Jr., Bergquist EJ, Hoopes JM. Sequelae and management of urinary infection in the patient requiring chronic catheterization. J Urol 1981;125:1-8.  Back to cited text no. 15
    
16.
Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med 1982;307:637-42.  Back to cited text no. 16
    
17.
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-63.  Back to cited text no. 17
    
18.
Tieszer C, Reid G, Denstedt J. Conditioning film deposition on ureteral stents after implantation. J Urol 1998;160:876-81.  Back to cited text no. 18
    
19.
Saklad M. Grading of patients for surgical procedures. Anesthesia 1941;2:281-4.  Back to cited text no. 19
    
20.
Keats AS. The ASA classification of physical statusA recapitulation. Anesthesiology 1978;49:233-6.  Back to cited text no. 20
    
21.
Fariñas MC, Martínez-Martínez L. Multiresistant Gram-negative bacterial infections: Enterobacteria, Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting Gram-negative bacilli. Enferm Infecc Microbiol Clin 2013;31:402-9.  Back to cited text no. 21
    
22.
Cantón R, Ruiz-Garbajosa P. Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.). Enferm Infecc Microbiol Clin 2013;31:543-51.  Back to cited text no. 22
    
23.
Yates JR 3rd. Mass spectrometry and the age of the proteome. J Mass Spectrom 1998;33:1-19.  Back to cited text no. 23
    
24.
Iacovelli V, Gaziev G, Topazio L, Bove P, Vespasiani G, Finazzi Agrò E. Nosocomial urinary tract infections: A review. Urologia 2014;81:222-7.  Back to cited text no. 24
    
25.
Franczyk J, Gray RR. Ureteral stenting in urosepsis: A cautionary note. Cardiovasc Intervent Radiol 1989;12:265-6.  Back to cited text no. 25
    
26.
Akay AF, Aflay U, Gedik A, Sahin H, Bircan MK. Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent. Int Urol Nephrol 2007;39:95-8.  Back to cited text no. 26
    
27.
Kehinde EO, Rotimi VO, Al-Hunayan A, Abdul-Halim H, Boland F, Al-Awadi KA. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 2004;18:891-6.  Back to cited text no. 27
    
28.
Farsi HM, Mosli HA, Al-Zemaity MF, Bahnassy AA, Alvarez M. Bacteriuria and colonization of double-pigtail ureteral stents: Long-term experience with 237 patients. J Endourol 1995;9:469-72.  Back to cited text no. 28
    
29.
Cronan JJ, Horn DL, Marcello A, Robinson A, Paolella LP, Lambiase RE, et al. Antibiotics and nephrostomy tube care: Preliminary observations. Part II. Bacteremia. Radiology 1989;172:1043-5.  Back to cited text no. 29
    
30.
Bahu R, Chaftari AM, Hachem RY, Ahrar K, Shomali W, El Zakhem A, et al. Nephrostomy tube related pyelonephritis in patients with cancer: Epidemiology, infection rate and risk factors. J Urol 2013;189:130-5.  Back to cited text no. 30
    
31.
Bonkat G, Widmer AF, Rieken M, van der Merwe A, Braissant O, Müller G, et al. Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation. World J Urol 2013;31:565-71.  Back to cited text no. 31
    
32.
Vargas-Cruz N, Reitzel RA, Rosenblatt J, Jamal M, Szvalb AD, Chaftari AM, et al. In vitro study of antimicrobial percutaneous nephrostomy catheters for prevention of renal infections. Antimicrob Agents Chemother 2017;61:e02596-16.  Back to cited text no. 32
    
33.
Lara-Isla A, Medina-Polo J, Alonso-Isa M, Benítez-Sala R, Sopeña-Sutil R, Justo-Quintas J, et al. Urinary infections in patients with catheters in the upper urinary tract: Microbiological study. Urol Int 2017;98:442-8.  Back to cited text no. 33
    

Top
Correspondence Address:
Dr. Chinmoy Sahu
Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareli Road, Lucknow - 226 014, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jgid.jgid_276_21

Rights and Permissions


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Methods
   Results
   Discussion
   Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed350    
    Printed20    
    Emailed0    
    PDF Downloaded44    
    Comments [Add]    

Recommend this journal

Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice | Contact Us
2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008